ANDA 83838, held by Hospira. Promethazine Hydrochloride.
As of Nov 16, 2026, ANDA 83838 (Promethazine Hydrochloride), held by Hospira, was first approved by FDA on Jan 21, 1974, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jan 21, 1974 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Promethazine Hydrochloride50MG/ML ยท injectable;injection | Promethazine Hydrochloride | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters